News
news release
Stock Code: 002653.SZ
Stock code: 002653.SZ
Business News
Xinhua Net: Haisco Technology Steps into the Top Tier of Innovation
Why is Cipepofol named 3486? How much is its efficacy increased by five times, and what clinical benefits does it bring? How did Haiscoo get its name? Where does the confidence of “in China, for the world” come from... On June 22, Xinhua Net published a in-depth report titled “Domestic anesthetic drugs ‘skip steps’ and receive FDA approval in the US; after fifteen years, Haiscoo enters the top tier of innovative drugs”. The full text is 2608 words. Now the original article is reprinted for readers.
Jun 26, 2026
Learn more
Business News
Xinhua Net: Class 1 innovative drug Youkepan is approved for Phase 7 of Nanjing’s “Ninghui Bao”, accelerating benefits for PNH patients
2026-09-24
Learn more
Business News
Haisco Co. launches the 2026 China Fair Competition Policy Promotion Week activity
2026-09-11
Learn more
Business News
One picture to understand | Haisco Co. releases 2026 semi-annual performance report
2026-08-27
Learn more
Business News
Haisco's independently developed pre-clinical autoimmune innovation drug has received an exclusive overseas license, with potential value exceeding $1.5 billion.
2026-08-26
Learn more
Business News
The new indication for the innovative drug HSK47388 tablets (I) has been approved, which is psoriatic arthritis.
2026-08-19
Learn more
Business News
Chinese Doctors' Day | Pay tribute to compassionate doctors
2026-08-19
Learn more
Business News
Xinhua News Agency’s “Half-Month Talk” focuses on Haisco’s innovative drugs’ moment on the market
2026-08-14
Learn more
Business News
The clinical trial of the innovative drug HSK60002 tablets has been approved for the treatment of inflammatory diseases.
2026-08-13
Learn more
Business News
At 8 p.m. last night, Haisco was featured on national television.
2026-08-05
Learn more
Haisco Group's Official WeChat Account
Haisco Investor Relations WeChat Account
Haisco Raw Materials Procurement Inquiries
COPYRIGHT 2026 @ HAISCO Pharmaceutical Group Co., Ltd.
Zang ICP Registration No. 20000012-1 Shu ICP Registration No. 16033962-2Shu ICP No. 16033962-3 The Tibetan public network security registration number is 54222102000053.(Tibetan)-Non-operational-2019-0003